The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.61
Bid: 0.00
Ask: 19.96
Change: 0.00 (0.00%)
Spread: 2.54 (14.581%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.61
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nanoco and Kyulux Inc. Sign Agreement

22 May 2017 07:00

RNS Number : 7329F
Nanoco Group PLC
22 May 2017
 

Nanoco and Kyulux Inc. Sign Agreement to Develop Next Generation Displays

 

The creation of Cadmium-Free Quantum Dot Hybrid QLED - OLED Technology Offers the Potential of Vastly Superior Displays

MANCHESTER, UK & CONCORD, Mass. USA, 22 May 2017 - Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, and Kyulux Inc., a world leader in developing and delivering the next generation of organic light emitting diode (OLED) technology today announced the signing of a collaboration and joint development agreement.

Under the agreement, Nanoco's heavy metal free quantum dots (CFQD quantum dots) will be combined with Kyulux's Hyperflourescent 'thermally activated delayed fluorescence' ("TADF") technology to create future generation hybrid OLED / QLED display technology with superior qualities to existing products in the display market.

In addition to offering a high degree of brightness and pure color, the combination of technologies means the displays will be cost effective for manufacturers and highly energy efficient for consumers.

"We are excited by the potential of this partnership, which brings together two global leaders in their fields," said Nanoco's Chief Executive Officer Michael Edelman. "By combining the best of quantum dot technology with the best of new generation OLED technology, we will bring world-class display technology to market. We have great confidence in our ability to deliver our current technology to the display market as planned. Innovation is core to Nanoco and this partnership complements our existing strategy to deliver cutting edge technology to the display market without increasing our cash burn."

 

"Kyulux is delighted to collaborate with Nanoco on this project, which will produce a vast improvement in display technology," said Christopher Savoie, Chief Executive Officer of Kyulux Inc. "As well as enhancing brightness and color, our next generation of display devices will be both cost effective and highly energy efficient. This will offer a technology breakthrough, particularly in the manufacture of ultra-high definition large screen devices."

 

Under the terms of the agreement, Nanoco and Kyulux will jointly develop and market this future display technology.

ABOUT KYULUX

Kyulux is a leader in developing and delivering the next generation of organic light emitting diode (OLED) technology, TADF. Kyulux develops and sells TADF and Hyperfluoresence based OLED materials and solutions to manufacturers in the display and lighting industries.

 Founded in 2015, the Company currently owns or has exclusive, co-exclusive or sole license rights to a large TADF intellectual property portfolio developed over the past seven years at Kyushu University and its industrial partners. Kyulux also enjoys a license to cutting-edge deep learning-based artificial intelligence technology for chemical discovery developed at Harvard University.

 Kyulux's cofounder and the inventor of TADF technology, Prof. Chihaya Adachi, is widely viewed as the top global researcher in OLED technology, having been a key author and inventor in all previous generations of OLED materials that are now used everyday by consumers across the globe.

Based in Fukuoka, Japan, with an advanced research and development center in Boston, Massachusetts. For further information please visit: www.kyulux.com

ABOUT NANOCO

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications:

· LCD display, where Nanoco's CFQD® quantum dots give consumers peace of mind to enjoy next-generation color performance and energy efficiency without allowing toxic chemicals into their homes.

· Lighting, where Nanoco's CFQD® quantum dots are used in horticulture to safely speed plant growth.

· Healthcare, where Nanoco's CFQD® quantum dots are opening new, potentially life saving uses in bio-imaging.

· Solar, where Nanoco's CFQD® quantum dots are incorporated into printable solar inks for future thin, highly efficient and low cost solar cells.

 

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany, and Wah Hong Industrial Corporation of Taiwan. Through these partners and its own production facilities in Runcorn, UK, Nanoco is creating the world's largest manufacturing ecosystem for cadmium-free quantum dots.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

For further information, please contact:

 

MHP Communications

Tel: +44 (0) 20 3128 8788

 

Reg Hoare / Andrew Leach / Giles Robinson

nanoco@mhpc.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASFSFMUFWSELI
Date   Source Headline
23rd Aug 20222:22 pmRNSFunded Law Suit Filed in Germany
19th Aug 20228:21 amRNSLitigation Update – Pre-Trial Conference
18th Aug 20224:10 pmRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSTrading Update
28th Jul 202210:42 amRNSHolding(s) in Company
13th Jul 20222:03 pmRNSReplacement - Director/PDMR Shareholding
13th Jul 202212:00 pmRNSHolding(s) in Company
13th Jul 202212:00 pmRNSDirector/PDMR Shareholding
13th Jul 202212:00 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSTotal Voting Rights
29th Jun 20227:00 amRNSChange of Auditor
23rd Jun 20223:48 pmRNSDirector/PDMR Shareholding
22nd Jun 20222:25 pmRNSHolding(s) in Company
21st Jun 20223:36 pmRNSDirector/PDMR Shareholding
21st Jun 20229:06 amRNSReplacement: Director/PDMR Shareholding
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
17th Jun 20224:36 pmRNSPrice Monitoring Extension
17th Jun 202210:45 amRNSHolding(s) in Company
14th Jun 20229:42 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSBlock listing Six-monthly Return
8th Jun 202212:00 pmRNSResults of Fundraise
8th Jun 20227:00 amRNSFundraise significantly over-subscribed
7th Jun 20225:16 pmRNSReplacement: Litigation Update
7th Jun 20224:55 pmRNSLitigation Update
6th Jun 20227:02 amRNSTrading Update & Proposed Fundraise
6th Jun 20227:00 amRNSMajor Work Package for European Customer
23rd May 20225:00 pmRNSHolding(s) in Company
17th May 20227:02 amRNSLitigation Update
13th May 202212:15 pmRNSHolding(s) in Company
13th Apr 20222:49 pmRNSHolding(s) in Company
12th Apr 20227:00 amRNSInterim Results
17th Mar 20227:00 amRNSAdditional Work Package for European Customer
15th Mar 20227:00 amRNSNotice of Interim Results
4th Feb 20223:14 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSTotal Voting Rights
9th Dec 20217:00 amRNSBlock listing Six-Monthly Return
2nd Dec 20217:18 amRNSBlock Listing Application
1st Dec 202112:30 pmRNSDirector/PDMR Shareholding
1st Dec 202112:28 pmRNSAnnual General Meeting – Voting Results
30th Nov 20217:00 amRNSAGM Statement
18th Nov 20211:13 pmRNSDirector/PDMR Shareholding
9th Nov 20217:11 amRNSDirector/PDMR Shareholding
8th Nov 20217:00 amRNSDirector Appointment
5th Nov 202111:25 amRNSAdditional Work Package for European Customer
4th Nov 20216:20 pmRNSNotice of AGM
3rd Nov 20217:00 amRNSPreliminary Results
18th Oct 20216:10 pmRNSChange to final results announcement date
13th Oct 20219:30 amRNSPresentation via Investor Meet Company
8th Oct 20211:48 pmRNSNotice of Results
19th Aug 20217:00 amRNSNon-Executive Director Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.